DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 156 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 0.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $338,170 | -9.7% | 26,627 | +0.1% | 0.00% | – |
| Q2 2023 | $374,481 | +110.8% | 26,606 | +131.3% | 0.00% | – |
| Q1 2023 | $177,681 | -98.7% | 11,504 | -97.2% | 0.00% | -100.0% |
| Q3 2021 | $13,838,000 | -7.2% | 407,237 | +0.0% | 0.01% | 0.0% |
| Q2 2021 | $14,905,000 | -22.0% | 407,128 | -4.4% | 0.01% | -33.3% |
| Q1 2021 | $19,105,000 | -0.0% | 426,077 | +27.2% | 0.01% | 0.0% |
| Q4 2020 | $19,109,000 | +11.1% | 334,838 | -0.1% | 0.01% | 0.0% |
| Q3 2020 | $17,201,000 | -14.0% | 335,306 | +0.1% | 0.01% | -18.2% |
| Q2 2020 | $20,006,000 | +44.5% | 335,002 | -0.4% | 0.01% | +10.0% |
| Q1 2020 | $13,847,000 | -72.1% | 336,336 | -57.9% | 0.01% | -60.0% |
| Q4 2019 | $49,681,000 | +63.5% | 798,224 | -10.8% | 0.02% | +56.2% |
| Q3 2019 | $30,386,000 | +99.4% | 895,281 | +32.5% | 0.02% | +100.0% |
| Q2 2019 | $15,237,000 | -0.8% | 675,707 | +2.1% | 0.01% | -11.1% |
| Q1 2019 | $15,358,000 | +4.2% | 661,679 | -5.8% | 0.01% | 0.0% |
| Q4 2018 | $14,745,000 | -44.0% | 702,496 | +3.4% | 0.01% | -35.7% |
| Q3 2018 | $26,310,000 | +19.7% | 679,498 | +21.6% | 0.01% | +7.7% |
| Q2 2018 | $21,989,000 | – | 558,815 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |